201 related articles for article (PubMed ID: 20980285)
1. Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab.
Ogata A; Morishima A; Hirano T; Hishitani Y; Hagihara K; Shima Y; Narazaki M; Tanaka T
Ann Rheum Dis; 2011 Jun; 70(6):1164-5. PubMed ID: 20980285
[No Abstract] [Full Text] [Related]
2. [New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)].
Nasonov EL
Ter Arkh; 2010; 82(5):64-71. PubMed ID: 20597275
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting interleukin-6 in rheumatoid arthritis.
Choy E
Curr Rheumatol Rep; 2008 Oct; 10(5):413-7. PubMed ID: 18817647
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 inhibition--tolerability profile and clinical implications.
Strand V; Yazici Y
Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S21-4. PubMed ID: 17708741
[TBL] [Abstract][Full Text] [Related]
5. Serious herpes zoster in rheumatoid arthritis under anti-interleukin-6 receptor antibody.
Kubandova Z; Mathieu S; Pourtier C; Soubrier M
Joint Bone Spine; 2010 Dec; 77(6):623-4. PubMed ID: 20851657
[No Abstract] [Full Text] [Related]
6. Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.
Snir A; Kessel A; Haj T; Rosner I; Slobodin G; Toubi E
Clin Exp Rheumatol; 2011; 29(4):697-700. PubMed ID: 21813064
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6: a new therapeutic target.
Smolen JS; Maini RN
Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S5. PubMed ID: 16899109
[TBL] [Abstract][Full Text] [Related]
8. [Biological agents for therapy of rheumatoid arthritis--overview].
Takeuchi T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():513-6. PubMed ID: 15799409
[No Abstract] [Full Text] [Related]
9. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
Genovese MC; McKay JD; Nasonov EL; Mysler EF; da Silva NA; Alecock E; Woodworth T; Gomez-Reino JJ
Arthritis Rheum; 2008 Oct; 58(10):2968-80. PubMed ID: 18821691
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials.
Kavanaugh A
Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S16-20. PubMed ID: 17708740
[TBL] [Abstract][Full Text] [Related]
11. Humanized antihuman IL-6 receptor antibody, tocilizumab.
Nishimoto N; Kishimoto T
Handb Exp Pharmacol; 2008; (181):151-60. PubMed ID: 18071945
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
Tanaka T; Kuwahara Y; Shima Y; Hirano T; Kawai M; Ogawa M; Arimitsu J; Hagihara K; Narazaki M; Ogata A; Kawase I; Kishimoto T
Arthritis Rheum; 2009 Dec; 61(12):1762-4. PubMed ID: 19950316
[No Abstract] [Full Text] [Related]
13. The role of tocilizumab in the management of rheumatoid arthritis.
Ash Z; Emery P
Expert Opin Biol Ther; 2012 Sep; 12(9):1277-89. PubMed ID: 22849354
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study.
Nishimoto N; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Azuma J
Ann Rheum Dis; 2009 Oct; 68(10):1580-4. PubMed ID: 19019888
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.
Patel AM; Moreland LW
Drug Des Devel Ther; 2010 Oct; 4():263-78. PubMed ID: 21116333
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with humanised anti-interleukin 6 receptor antibody for multidrug-refractory and anti-tumour necrosis factor-resistant systemic rheumatoid vasculitis.
Sumida K; Ubara Y; Takemoto F; Takaichi K
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S133. PubMed ID: 21385558
[No Abstract] [Full Text] [Related]
17. Interleukin-6 in rheumatoid arthritis.
Nishimoto N
Curr Opin Rheumatol; 2006 May; 18(3):277-81. PubMed ID: 16582692
[TBL] [Abstract][Full Text] [Related]
18. [Humanized anti-human IL-6 receptor antibody, tocilizumab].
Nishimoto N
Nihon Rinsho; 2007 Jul; 65(7):1218-25. PubMed ID: 17642235
[TBL] [Abstract][Full Text] [Related]
19. Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin-6 receptor monoclonal antibody.
Ogawa J; Harigai M; Akashi T; Nagasaka K; Suzuki F; Tominaga S; Miyasaka N
Ann Rheum Dis; 2006 Dec; 65(12):1667-9. PubMed ID: 17105857
[No Abstract] [Full Text] [Related]
20. Tocilizumab for rheumatoid arthritis.
Drug Ther Bull; 2010 Jan; 48(1):9-12. PubMed ID: 20040568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
